COVID-19

The Rapid SARS-CoV-2 Antigen Test Card is a rapid, chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigens present on human nasal, nasopharyngeal or oropharyngeal swab specimens.

• CE marked
• For professional use only
• Pre-filled tubes

In vitro quantitative determination of anti-SARS-CoV2 IgG concentrations from human samples of plasma, tissue homogenates and other biological fluids.

In vitro quantitative determination of COVID-19 nucleoprotein concentrations in plasma, tissue homogenates and other biological fluids from various mammalian species.

• CE certified self-test for private use/home use
• Minimal Order Quantity: 10 000 tests
• Approved by Health Authorities in many European Countries
• Detect the Omicron variants BA.1 and BA.2 as well as the subvariants BA.3, BA.4 & BA.5

The Rapid SARS-CoV-2 Antigen Test Card is an in-vitro diagnostic test for private use. It is used to detect SARS-CoV-2 antigens from anterior nasal swabs. 

In vitro quantitative determination of anti-SARS-CoV2 IgM concentrations from human samples of plasma, tissue homogenates and other biological fluids.

Designed for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019-nCoV, SARS-CoV-2) in human serum, plasma or whole blood.

Recombinant His-tagged human ACE2 (Met1-Ser740) with polyhistidine tag at the N- and C-terminus. Expressed in E. coli.

Monoclonal antibody raised against the coronavirus spike S1 protein, a common target for neutralizing antibodies and vaccines.

Monoclonal antibody raised against the coronavirus spike S2 (B) protein, a common target for neutralizing antibodies and vaccines.

Monoclonal antibody raised against the coronavirus spike S2 protein, a common target for neutralizing antibodies and vaccines.